This proposal is to pursue a highly innovative general theory that integrates evolution, developmental biology, epigenetics, and disease. Epigenetics is the study of information heritable during cell division other than the DNA sequence, and it underlies normal development and is important in cancer and possibly other common disease. I have been involved in this field since my discovery of altered DNA methylation in cancer in 1983. Since that time, I and others have grappled with how to incorporate epigenetics into evolutionary thinking. Some have proposed a Lamarckian inheritance of epigenetic marks, that is, environmentally directed epigenetic changes, which in my view is with rare exceptions an implausible mechanism over the long term because of powerful gametic reprogramming. I suggest a new inherited stochastic variation model in which genetic variants that do not result in mean observable phenotypes, but could change the variability of the observed phenotypes through epigenetic mechanisms. These heritable genetic variants for increased epigenetic variance would be found at genes in which the direction of environmental selection (positive or negative) fluctuates over long periods of time. Such variants for variation would be mediated epigenetically, for example, stochastic variation in DNA methylation in an isogenic background. At the same time, by increasing the tails at both ends of a phenotype distribution curve, there would be increased disease susceptibility in a recently changed environment, such as the Western diet. I have found three lines of preliminary data supporting this new idea: highly variable regions of DNA methylation in a given tissue in inbred mice raised in the same environment, and regulating key genes for development;mouse/human differences in DNA sequence in which one species has this variation and another does not;and a link between some these variably methylated regions and body mass index. My specific plans are: (1) to test the role of stochastic epigenetic plasticity in normal differentiation;(2) to study developmental epigenetics in a model organism, the honey bee Apis mellifera, in particular the idea that genetic variants with developmental differences (such as high and low pollen producers) have genetically assimilated sites of epigenetic variability;(3) to develop a mathematical model for epigenetic plasticity and its relationship to genetic variation;and (4) to investigate epigenetic plasticity in human populations, and to identify sequences regulating epigenetic plasticity. This highly innovative proposal represents a completely new direction for my research, and could have profound influence on our understanding of epigenetics, developmental biology, population variation and disease. Project Description

Agency
National Institute of Health (NIH)
Institute
Office of The Director, National Institutes of Health (OD)
Type
NIH Director’s Pioneer Award (NDPA) (DP1)
Project #
1DP1OD008324-01
Application #
8143925
Study Section
Special Emphasis Panel (ZGM1-NDPA-A (01))
Program Officer
Wehrle, Janna P
Project Start
2011-09-30
Project End
2012-07-31
Budget Start
2011-09-30
Budget End
2012-07-31
Support Year
1
Fiscal Year
2011
Total Cost
$810,000
Indirect Cost
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Pujadas, Elisabet; Feinberg, Andrew P (2012) Regulated noise in the epigenetic landscape of development and disease. Cell 148:1123-31
Herb, Brian R; Wolschin, Florian; Hansen, Kasper D et al. (2012) Reversible switching between epigenetic states in honeybee behavioral subcastes. Nat Neurosci 15:1371-3